These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29462967)

  • 21. Effects of EphB4 receptor expression on colorectal cancer cells, tumor growth, vascularization and composition.
    Kadife E; Ware TMB; Luwor RB; Chan STF; Nurgali K; Senior PV
    Acta Oncol; 2018 Aug; 57(8):1043-1056. PubMed ID: 29368976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination.
    Lennon S; Oweida A; Milner D; Phan AV; Bhatia S; Van Court B; Darragh L; Mueller AC; Raben D; Martínez-Torrecuadrada JL; Pitts TM; Somerset H; Jordan KR; Hansen KC; Williams J; Messersmith WA; Schulick RD; Owens P; Goodman KA; Karam SD
    Clin Cancer Res; 2019 Jun; 25(11):3352-3365. PubMed ID: 30944125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship between multi-slice spiral CT pulmonary perfusion imaging and the expression of EphB4 and ephrinB2 in non-small cell lung cancer].
    Xiong Z; Liu JK; Zhou ML; Hu CP; Zhou H; Chen W
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):192-6. PubMed ID: 21575518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct EphB4-mediated mechanisms of apoptotic and resistance to dasatinib in human chronic myeloid leukemia and K562 cell lines.
    Zhao WH; Huang BT; Zhang JY; Zeng QC
    Leuk Res; 2017 Dec; 63():28-33. PubMed ID: 29096333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
    Füller T; Korff T; Kilian A; Dandekar G; Augustin HG
    J Cell Sci; 2003 Jun; 116(Pt 12):2461-70. PubMed ID: 12734395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell.
    Li X; Li Z; Li X; Liu B; Liu Z
    BMC Cancer; 2017 May; 17(1):357. PubMed ID: 28532456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand.
    Rutkowski R; Mertens-Walker I; Lisle JE; Herington AC; Stephenson SA
    Int J Cancer; 2012 Sep; 131(5):E614-24. PubMed ID: 22161689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer.
    Kumar SR; Singh J; Xia G; Krasnoperov V; Hassanieh L; Ley EJ; Scehnet J; Kumar NG; Hawes D; Press MF; Weaver FA; Gill PS
    Am J Pathol; 2006 Jul; 169(1):279-93. PubMed ID: 16816380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EphB4 forward-signaling regulates cardiac progenitor development in mouse ES cells.
    Chen K; Bai H; Liu Y; Hoyle DL; Shen WF; Wu LQ; Wang ZZ
    J Cell Biochem; 2015 Mar; 116(3):467-75. PubMed ID: 25359705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological Significance of EphB4 Expression in Cancer.
    Ullah A; Razzaq A; Zhou C; Ullah N; Shehzadi S; Aziz T; Alfaifi MY; Elbehairi SEI; Iqbal H
    Curr Protein Pept Sci; 2024; 25(3):244-255. PubMed ID: 37909437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy.
    Ehlken C; Martin G; Lange C; Gogaki EG; Fiedler U; Schaffner F; Hansen LL; Augustin HG; Agostini HT
    Acta Ophthalmol; 2011 Feb; 89(1):82-90. PubMed ID: 19764912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.
    Erber R; Eichelsbacher U; Powajbo V; Korn T; Djonov V; Lin J; Hammes HP; Grobholz R; Ullrich A; Vajkoczy P
    EMBO J; 2006 Feb; 25(3):628-41. PubMed ID: 16424904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ephrin‑B2 inhibits cell proliferation and motility in vitro and predicts longer metastasis‑free survival in breast cancer.
    Magic Z; Sandström J; Perez-Tenorio G
    Int J Oncol; 2019 Dec; 55(6):1275-1286. PubMed ID: 31638179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The novel PI3 kinase inhibitor, BAY 80-6946, impairs melanoma growth in vivo and in vitro.
    Schneider P; Schön M; Pletz N; Seitz CS; Liu N; Ziegelbauer K; Zachmann K; Emmert S; Schön MP
    Exp Dermatol; 2014 Aug; 23(8):579-84. PubMed ID: 24942196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET imaging of colorectal and breast cancer by targeting EphB4 receptor with 64Cu-labeled hAb47 and hAb131 antibodies.
    Liu S; Li D; Park R; Liu R; Xia Z; Guo J; Krasnoperov V; Gill PS; Li Z; Shan H; Conti PS
    J Nucl Med; 2013 Jul; 54(7):1094-100. PubMed ID: 23667241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells.
    Herwig N; Belter B; Wolf S; Haase-Kohn C; Pietzsch J
    J Cell Mol Med; 2016 May; 20(5):825-35. PubMed ID: 26928771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Casticin Induced Apoptosis in A375.S2 Human Melanoma Cells through the Inhibition of NF-[Formula: see text]B and Mitochondria-Dependent Pathways In Vitro and Inhibited Human Melanoma Xenografts in a Mouse Model In Vivo.
    Shiue YW; Lu CC; Hsiao YP; Liao CL; Lin JP; Lai KC; Yu CC; Huang YP; Ho HC; Chung JG
    Am J Chin Med; 2016; 44(3):637-61. PubMed ID: 27109154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, radiolabelling and initial biological characterisation of
    Pretze M; Neuber C; Kinski E; Belter B; Köckerling M; Caflisch A; Steinbach J; Pietzsch J; Mamat C
    Org Biomol Chem; 2020 Apr; 18(16):3104-3116. PubMed ID: 32253415
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.